FDA Inspection 1082467 — Joslin Diabetes Center Committee On Human Studies

Joslin Diabetes Center Committee On Human Studies — FEI 1283624

The FDA completed an inspection of Joslin Diabetes Center Committee On Human Studies on Nov 27, 2018 in Boston, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Nov 27, 2018
Fiscal Year
2019
Product Type
Devices
Project Area
Bioresearch Monitoring
Location
Boston, MA (United States)

Additional details

IRB

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.